Clinical Trials
9
Active:1
Completed:7
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Not Applicable
Not yet recruiting
- Conditions
- InfectionInfections, BacterialInfections, FungalInfection ViralParasitic Disease
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-27
- Lead Sponsor
- Karius, Inc.
- Target Recruit Count
- 2000
- Registration Number
- NCT07110636
Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens
Completed
- Conditions
- Pneumonia FungalPneumonia, BacterialPneumonia, ViralPneumonia CavitaryImmunocompromised Host
- First Posted Date
- 2019-08-07
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Karius, Inc.
- Target Recruit Count
- 257
- Registration Number
- NCT04047719
- Locations
- 🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸UCSF Department of Medicine, San Francisco, California, United States
🇺🇸University of Colorado Denver, Aurora, Colorado, United States
Detection of Dengue Virus in Plasma of Patients in Nepal
Completed
- Conditions
- Dengue Fever
- First Posted Date
- 2018-08-08
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- Karius, Inc.
- Target Recruit Count
- 643
- Registration Number
- NCT03620487
- Locations
- 🇳🇵
Tribhuvan University, Kirtipur, Nepal
Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients
Completed
- Conditions
- NeutropeniaFever
- First Posted Date
- 2018-05-21
- Last Posted Date
- 2023-02-10
- Lead Sponsor
- Karius, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT03530072
- Locations
- 🇺🇸
Lucille Packard Children's Hopsital, Stanford, California, United States
Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
Completed
- Conditions
- Invasive Fungal InfectionsInvasive Fungal DiseaseFever and NeutropeniaImmunocompromised
- First Posted Date
- 2017-08-25
- Last Posted Date
- 2019-06-17
- Lead Sponsor
- Karius, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT03262584
- Locations
- 🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Prev
- 1
- 2
- Next
News
No news found